fluoxetine has been researched along with Hemolysis in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To this end cell volume was estimated from forward scatter, phosphatidylserine exposure from annexin V binding, hemolysis from hemoglobin release and [Ca2+]i from Fluo-3 fluorescence intensity." | 3.79 | Fluoxetine induced suicidal erythrocyte death. ( Abed, M; Almilaji, A; Bissinger, R; Enkel, S; Jilani, K; Lang, F, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jilani, K | 1 |
| Enkel, S | 1 |
| Bissinger, R | 1 |
| Almilaji, A | 1 |
| Abed, M | 1 |
| Lang, F | 1 |
1 other study available for fluoxetine and Hemolysis
| Article | Year |
|---|---|
Fluoxetine induced suicidal erythrocyte death.
Topics: Aniline Compounds; Annexin A5; Antidepressive Agents, Second-Generation; Apoptosis; Calcium; Cell Si | 2013 |